mazdutide and tirzepatide together Mazdutide: An emerging glucagon/GCG-like peptide-1 dual receptor agonist for obesity—a comparison of therapeutic effects potential side effects with GCG-like peptide-1 inhibitors Mazdutide: Mechanism, Effects & Research

Improved blood sugar control: Helps regulate blood sugar levels, making it beneficial for individuals with type 2 diabetes

Allergic reactions were reported in four patients in the SUSTAIN program

The peptide ipamorelin has not been approved for use in humans by the United States Food and Drug Administration (FDA), nor by any of its international regulatory counterparts

It should not be considered a substitute for any prescribed medication

As our understanding of this topic continues to evolve, ongoing discussions and collaboration between patients and healthcare providers remain key to informed decision-making and optimal care